WO2004030720A2 - Transnasal method and catheter for lacrimal system - Google Patents

Transnasal method and catheter for lacrimal system Download PDF

Info

Publication number
WO2004030720A2
WO2004030720A2 PCT/US2003/030691 US0330691W WO2004030720A2 WO 2004030720 A2 WO2004030720 A2 WO 2004030720A2 US 0330691 W US0330691 W US 0330691W WO 2004030720 A2 WO2004030720 A2 WO 2004030720A2
Authority
WO
WIPO (PCT)
Prior art keywords
distal
segment
distal segment
catheter
catheter body
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2003/030691
Other languages
French (fr)
Other versions
WO2004030720A3 (en
Inventor
Bruce B. Becker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quest Medical Inc
Original Assignee
Quest Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quest Medical Inc filed Critical Quest Medical Inc
Priority to CA2499222A priority Critical patent/CA2499222C/en
Priority to JP2004541840A priority patent/JP2006515997A/en
Priority to MXPA05003261A priority patent/MXPA05003261A/en
Priority to AU2003273371A priority patent/AU2003273371A1/en
Priority to EP03755869A priority patent/EP1545647B1/en
Publication of WO2004030720A2 publication Critical patent/WO2004030720A2/en
Publication of WO2004030720A3 publication Critical patent/WO2004030720A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M29/00—Dilators with or without means for introducing media, e.g. remedies
    • A61M29/02—Dilators made of swellable material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00772—Apparatus for restoration of tear ducts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/24—Surgical instruments, devices or methods for use in the oral cavity, larynx, bronchial passages or nose; Tongue scrapers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/10—Balloon catheters
    • A61M2025/1043—Balloon catheters with special features or adapted for special applications
    • A61M2025/1093—Balloon catheters with special features or adapted for special applications having particular tip characteristics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0618—Nose

Definitions

  • This invention relates to a method and catheter for treating the lacrimal system and, more particularly, to a transnasal method of treating the lacrimal system and a balloon catheter used in this method.
  • the orbital portion of the lacrimal gland is located in the superotemporal orbit and produces the aqueous layer of the tear film. Ductules from the orbital portion of the lacrimal gland pass through the adjacent palpebral lacrimal gland to empty in the superior conjunctival cul-de-sac. Smaller accessory lacrimal glands in the upper and lower lids also contribute to tear production.
  • the tears bathe the surface of the eye and then drain into the puncta and canaliculi in the medial upper and lower lids. The tears flow from the canaliculi into the lacrimal sac down the nasolacrimal duct into the nose.
  • the nasolacrimal duct can.become obstructed on either a congenital or acquired basis.
  • tears can no longer drain from the surface of the eye through the lacrimal system into the nose. The tears well up over the eye and spill over the fids onto the face.
  • the patient has to constantly dab the eye with a tissue.
  • tears stagnate in the lacrimal sac bacteria multiply, and in many cases the lacrimal sac becomes infected (dacryocystitis). Dacryocystitis causes the lacrimal sac to become swollen, red and painful. Pus exudes from the sac and constantly covers the eye.
  • Dacryocystorhinostomy is the surgery required to correct nasolacrimal duct obstruction.
  • a new opening is created between the lacrimal sac and the nose. This allows tears to flow from the lacrimal sac
  • An external or incisional DCR require an incision on the side of the nose.
  • the surgeon creates a large 17mm plus diameter opening in the bone and nasal muscosa. This procedure has significant morbidity, a prolonged recovery, and the threat of scarring and hemorrhage.
  • an endoscopic DCR has much less morbidity, no incision, and a quick recovery time.
  • An endoscopic DCR may be performed using a balloon catheter, a laser, or traditional surgical instruments.
  • a laser endoscopic DCR requires expensive and time-consuming lasers, and has a low success rate.
  • An endoscopic DCR with traditional instruments places the eye and surrounding structures at risk because tissue is removed from the lacrimal sac and lateral nasal wall, with the instruments in the nasal cavity going toward the eye and orbit. Bleeding and edema may make it difficult to identify the relevant structures.
  • a balloon catheter DCR is a much safer and cheaper form of DCR than a laser or an endoscopic DCR with traditional surgical instruments.
  • the balloon catheter is positioned so that it extends from the lacrimal sac through the ostium and extends into the nose.
  • the balloon DCR ostium is created by dilatation, rather than by excision or laser energy, there ' is no threat to the surrounding ocular and orbital structures, and there is less tissue trauma.
  • a 5mm diameter ostium is much smaller than the 17mm plus diameter ostium of an external DCR and leads to a higher stenosis rate of the balloon DCR ostium after surgery.
  • a larger diameter balloon would create a larger-diameter ostium and lead to a higher surgical success rate.
  • the surgeon then reaches up the nose with a hemostat or other instrument to grasp the guide wire and pull it out of the external naris of the nose.
  • a flexible balloon catheter is then passed up the nose over the guide wire and through the lateral nasal wall into the lacrimal sac, or up the nasolacrimal duct into the lacrimal sac.
  • the guide wire may pass posteriorly into the throat (pharynx) rather than in the direction of the external naris.
  • the 5,169,386 patent also discloses an alternative dilation catheter, which does not use a guide wire, but there is no suggestion that this catheter be inserted transnasally.
  • the catheter is constructed to simulate a standard ophthalmic probe in stiffness, in terms of both column strength and resistance to lateral bending, with sufficient flexibility to enable it to conform to the contours of the lacrimal system.
  • the catheter as provided, is initially straight, but the catheter may be bent between 0°- 30° to simulate the curvature of an ophthalmic probe.
  • a curve retention element is inserted in the catheter to retain the curved shape and to increase the columnar and flexural stiffiiess of the distal portion of the catheter to enhance its ability to be forced through a constricted portion of the lacrimal system.
  • the catheter is formed of a stainless steel hypotube having an outer diameter of 0.022" and an inner diameter of 0.017".
  • This catheter is not suitable for transnasal insertion.
  • the tube does not have sufficient stiffness and column strength to enable the deflated balloon catheter to be pushed from the nasal cavity through a small, tight opening in the lateral nasal wall and lacrimal fossa into the lacrimal sac.
  • the bent distal portion is not angled to a degree necessary for ready insertion through the opening.
  • a balloon catheter of the invention can be introduced transnasally into the area of a planned DCR ostium.
  • the catheter has a larger deflated profile and, thus, a larger inflated diameter, than a balloon catheter introduced through the delicate canaliculi.
  • the balloon catheter of the invention does not need a guide wire; and, therefore, there is no chance that a guide wire will damag ⁇ 'the delicate canaliculi.
  • a larger diameter balloon DCR ostium is less likely to stenose after surgery and results in a better surgical success rate.
  • the balloon catheter of the invention comprises a hypotube formed of stainless steel of sufficient stiffiiess and column strength to enable the deflated balloon catheter to be pushed from the nasal cavity through a prepared small, tight opening in the lateral nasal wall and lacrimal fossa into the lacrimal sac.
  • a distal end segment of the hypotube has a rounded bend, placing the distal segment at an angle of 70° to 115°, preferably 90°, to a long proximal segment or shaft. This bend allows the surgeon to rotate or shift the position of the long proximal catheter shaft, thus placing the distal balloon catheter segment in position to enter from the nasal cavity into the lacrimal sac at various angles appropriate to each individual patient. Due to the stiffiiess and strength of the hypotube, neither a guide wire nor a curve retention element are necessary.
  • the distal segment of the balloon catheter from the outside of the bend to the end of the catheter is 14mm which is short enough to allow it to be rotated within the nasal cavity and long enough to allow a balloon of sufficient length and diameter to be attached to the hypotube for dilatation of the balloon DCR ostium.
  • the balloon is formed of inflatable material with a first neck bonded with adhesive to the very distal portion of the distal segment of the hypotube and a second neck bonded with adhesive to the distal end of the proximal shaft, the bend, and the proximal end of the distal segment.
  • the proximal end of the catheter tube has a luer lock with wings or an expansion to allow the catheter to be attached to tubing from the inflation device. The wings or expansion allow the surgeon to more easily hold, manipulate, and push the balloon catheter.
  • a very large ostium is formed between the lacrimal sac and the nasal cavity with the use of a very large balloon inserted transnasally.
  • the balloon is deflated to allow the catheter, which is of sufficient stiffness, to be pushed through the prepared opening formed from the nasal cavity through the lateral nasal wall and lacrimal fossa into the lacrimal sac.
  • the balloon is then inflated to enlarge the opening and create the very large ostium.
  • the balloon catheter is inserted without the use of a guide wire.
  • the portion of the distal end after the bend is sufficiently short to enable the catheter to be positioned in the nasal cavity to bring the distal end to the level of the prepared opening.
  • the catheter is then rotated or shifted to align the distal end with the prepared opening, as required by the anatomy of the individual patient.
  • the distal end is then pushed through the prepared opening to position the deflated balloon in the opening.
  • the balloon is then inflated to enlarge the opening to the outer diameter of the inflated balloon, thus fora-ing the very large ostium.
  • the catheter and method of the invention provide a satisfactory endoscopic DCR and thus avoid the trauma associated with an external (incisional) DCR.
  • the catheter and method of the invention achieve a high surgical success rate.
  • FIG. 1 is a schematic drawing of a preferred embodiment of a lacrimal balloon catheter of the invention
  • Fig. la is a close-up schematic drawing of the tip of the distal segment of the balloon catheter of Fig. 1;
  • Fig. 2 is a schematic drawing of a step of the method of the invention showing a patient with an obstructed nasolacrimal duct in which a metal probe has been passed through the punctum, canaliculus, lacrimal sac, and multiple spots in the lacrimal fossa and lateral nasal wall into the nose;
  • Fig. 3 is a schematic drawing showing another step of the method of the invention in which a nerve hook brought up the nasal cavity, pushed into the small openings in the lateral nasal wall and lacrimal fossa, and moved to coalesce these small openings into a larger opening;
  • Fig. 4 is a schematic drawing showing a further step of the method of the invention in which a deflated balloon catheter of the invention, which has been brought into the nasal cavity and pushed through the small opening in the lateral nasal wall and lacrimal fossa into the lacrimal sac; '
  • Fig. 5 is a schematic drawing showing a step of the method of the invention in which the balloon catheter with the balloon inflated is within the ostium and lacrimal sac; and Fig. 6 is a close-up schematic drawing of the tip of the distal portion of an alternative embodiment of a balloon catheter of the invention.
  • Fig. 7 is a schematic diagram showing a method step of an alternative embodiment of the method of the invention.
  • a balloon catheter 130 of the invention is assembled from a tube 136, preferably a stainless steel hard tempered hypotube which has a circular bend 138 of 0.13" radius such that distal segment 137 is oriented 70° to 115°, preferably 90°, to proximal segment 139.
  • the distance from the distal tip 184 of distal segment 137 to the outer wall of proximal segment 139 of hypotube 136 is 4mm to 30mm, preferably 14mm, as shown in Fig. 1.
  • the distal tip 184 of the hypotube 136 is closed, whereas the proximal end 142 is open.
  • the lumen of tube 136 may be closed in the distal s ntie t 137, up to 10mm from the distal tip 184 allowing the distal tip 184 to remain open for engagement with a probe, as shown in Figs. 6 and 7.
  • the proximal end 142 of hypotube 136 is inserted into a mold for forming luer 144. Heated plastic is injected into the mold to form luer 144 attached to proximal end 142.
  • the inner diameter of the luer 144 matches the external diameter of the hypotube 136.
  • the luer 144 has wings 143 or other enlargement or expansion on it to enable the surgeon to better hold and manipulate the balloon catheter 130.
  • Catheter 130 is 4" to 10" long, preferable 6" in length as measured from proximal end 142 to distal tip 184, as shown in Fig. 1.
  • the wall of tube 136 should be of such thickness that the tube has sufficient stiffiiess and column strength that distal segment 137 of a deflated catheter can be pushed through a prepared small, tight opening in the patient's lateral nasal wall. This may require considerable pressure in some cases. It has been found that a tube with a wall thickness of at least 0.035" will be satisfactory.
  • a preferred tube has an outer diameter of 0.083" and an inner diameter of 0.039" with a wall thickness of 0.044".
  • the catheter 130 has a port 140 in the distal segment 137, which is formed by inserting temporarily a discardable wire segment into the tube 136. This is done before inserting hypotube 136 into luer 144.
  • a transverse slot is cut in the tube 136 approximately 2mm to 14mm, preferably 4mm, from its distal end 184 to form portT4 ⁇ ) The slot extends in depth to approximately one third of the diameter of tube 136.
  • a wire wheel is used to remove any burrs, and the discardable core wire is removed and discarded.
  • Catheter 130 has sufficient column strength and resistance to lateral bending (stiffiiess) to enable the deflated catheter to be pushed through the initial prepared opening in the lateral nasal wall and lacrimal fossa into the lacrimal sac. This may require considerable pressure in some cases.
  • a balloon 134 is preferably formed of polyethylene terephthalate and has a length of approximately 4mm to 30mm, preferably 14mm, and a working inflated diameter of 2mm to 14mm, preferably 9mm, for use in the lacrimal system.
  • the balloon has a distal neck 170, a distal tapered region 172, a center region 174, a proximal tapered region 176, and a proximal neck 178.
  • tube 136 is cleaned with isopropanol and then coated with a primer, "Loctite 770.” The balloon is placed over the distal end of tube 136 to align the distal end of distal neck 170 with distal end 184 of tube 136.
  • An adhesive such as cyanoacrylate, is used.
  • An acceptable adhesive "Loctite 4081" is available from Loctite Corporation.
  • the adhesive is applied to distal end of distal neck 170 and the proximal end of proximal neck 178 to form bonds 180 and 182, respectively.
  • the adhesive is applied to the balloon necks 170, 178 using a small mandrel such as a wire approximately 0.010" to 0.014" in diameter.
  • the adhesive wicks into the necks due to capillary action.
  • Proximal neck 178 and proximal tapered region 176 may be bonded oh distal segment 137 of tube 136 or extend over bend 138 onto the distal end portion of proximal segment 139 of tube 136. Extension of the proximal neck 178 onto bend 138 and proximal segment 139 allows a greater length of the working diameter, i.e., center region 174, to be on distal segment 137 of tube 136.
  • a first step of the method of the invention is shown in Fig. 2.
  • a Bowman probe 102 is brought through superior punctum 4 of the patient's eye, superior canaliculus 6, common canaliculus 8, and lacrimal sac 10, and then pushed through the medial sac wall 11, lacrimal fossa bone 12, and lateral nasal wall 44 into the nasal cavity 38.
  • Probe 102 is pulled back into lacrimal sac 10, and pushed through four or fives areas of medial sac wall 11, lacrimal fossa bone 12, and lateral nasal wall 44 into nasal cavity 38.
  • the multiple openings 18 in the medial sac wall 11, lacrimal fossa 12, and lateral nasal wall 44 are coalesced into one prepared opening 19 (Fig. 4) by moving probe 102 in a see-saw fashion or by bringing a nerve hook 104 into nasal cavity 38, and pushing it into openings 18 and dragging nerve hook 104 across multiple openings, as shown in Fig. 3.
  • the deflated transnasal lacrimal balloon catheter 130 is then brought into nasal cavity 38, and distal segment 137 is pushed through prepared opening 19 created by coalescing smaller openings 18 in lateral nasal wall 44, lacrimal fossa 12, and medial wall 11 of lacrimal sac 10, such that distal end 184 of distal segment 137 of balloon catheter 130 extends into lacrimal sac 10.
  • the luer lock 144 on proximal end 142 of balloon catheter 130 connects to the distal end 110 of tube 112 of the inflation device, which supplies fluid under pressure.
  • balloon 134 is inflated to 9 bars for 20 seconds to expand opening 19 to form ostium 120 then deflated.
  • Distal segment 137 is then slightly repositioned to insure thorough dilation and inflated again to 9 bars for 20 seconds.
  • Balloon 134 is then deflated and withdrawn from nasal cavity 38, leaving a large ostium 120 formed between lacrimal sac 10 and nasal cavity 38.
  • the catheter 230 has a distal segment 237, which are identical to catheter 130 and segment 137, as shown in Fig. 1, except for the point of closure of tube 136.
  • distal segment 137 in Fig. 1 is closed at its distal end 184, in the embodiment of Fig. 6, tube 236, and distal segment 237 are closed by closure wall 286 that is located between slot 140 Lnd the distal end 284. Since distal segment 237 is closed after (Sot 140 ' fluid will still flow througlvslot 140)to ir ⁇ flate(balloon 134Jwhen air under pressure is applied to tube 236.
  • this open-ended tube segment 288 may be used to receive an end of a probe 202, provided that the outer diameter of probe 202 is slightly smaller than the inner diameter of tube segment 288.
  • Such a probe engaged with open-ended tube segment 288 can be useful for moving distal end 284 to a proper position for engagement with an opening 19 which is to be enlarged by inflating/balloon 13 1s described above.

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Surgical Instruments (AREA)

Abstract

A balloon catheter (130) for treatment of a patient's lacrimal system is without the use of a guide wire or a curve retention member. The catheter (130) is formed of a stainless steel hypotube (136) and is of sufficient stiffness and column strength to enable the catheter (130) to be pushed from the patent's nasal cavity through a small-tight opening into the lacrimal sac. The catheter (130) has a proximal shaft (139) and a distal segment (137) positioned by a bend (138) of 70° to 115°, preferably 90°, to the proximal shaft (139). An inflatable member (134) is mounted about the distal segment (137). The small-tight opening is formed by pushing small holes through the medial sac, lacrimal fossa, and lateral nasal wall with an instrument (102, 104). The catheter (130) is introduced into the nasal cavity. The distal segment (137) is then pushed through the opening, and fluid under pressure is applied to the catheter (130).

Description

TRANSNASAL METHOD AND CATHETER FOR LACBIMAL SYSTEM
1. Field of the Invention
This invention relates to a method and catheter for treating the lacrimal system and, more particularly, to a transnasal method of treating the lacrimal system and a balloon catheter used in this method.
2. Background and Description of the Prior Art
To fully understand the invention, it is necessary to consider the anatomy and physiology of the lacrimal system. The orbital portion of the lacrimal gland is located in the superotemporal orbit and produces the aqueous layer of the tear film. Ductules from the orbital portion of the lacrimal gland pass through the adjacent palpebral lacrimal gland to empty in the superior conjunctival cul-de-sac. Smaller accessory lacrimal glands in the upper and lower lids also contribute to tear production. The tears bathe the surface of the eye and then drain into the puncta and canaliculi in the medial upper and lower lids. The tears flow from the canaliculi into the lacrimal sac down the nasolacrimal duct into the nose.
The nasolacrimal duct can.become obstructed on either a congenital or acquired basis. When the nasolacrimal duct becomes obstructed, tears can no longer drain from the surface of the eye through the lacrimal system into the nose. The tears well up over the eye and spill over the fids onto the face. The patient has to constantly dab the eye with a tissue. In addition, tears stagnate in the lacrimal sac, bacteria multiply, and in many cases the lacrimal sac becomes infected (dacryocystitis). Dacryocystitis causes the lacrimal sac to become swollen, red and painful. Pus exudes from the sac and constantly covers the eye. In time, the dacryocystitis does not respond to antibiotics and surgery becomes necessary. At present, there is no medical therapy for acquired nasolacrimal duct obstruction other than antibiotics to temporarily suppress infection. The condition can, however, be corrected surgically. Dacryocystorhinostomy (DCR) is the surgery required to correct nasolacrimal duct obstruction. In a DCR, a new opening (ostium) is created between the lacrimal sac and the nose. This allows tears to flow from the lacrimal sac
5 through the DCR ostium into the nose. An external or incisional DCR require an incision on the side of the nose. In an open DCR, the surgeon creates a large 17mm plus diameter opening in the bone and nasal muscosa. This procedure has significant morbidity, a prolonged recovery, and the threat of scarring and hemorrhage. In contrast, an endoscopic DCR has much less morbidity, no incision, and a quick recovery time. An endoscopic DCR may be performed using a balloon catheter, a laser, or traditional surgical instruments. A laser endoscopic DCR requires expensive and time-consuming lasers, and has a low success rate. An endoscopic DCR with traditional instruments places the eye and surrounding structures at risk because tissue is removed from the lacrimal sac and lateral nasal wall, with the instruments in the nasal cavity going toward the eye and orbit. Bleeding and edema may make it difficult to identify the relevant structures.
It has been found that a balloon catheter DCR is a much safer and cheaper form of DCR than a laser or an endoscopic DCR with traditional surgical instruments. The balloon catheter is positioned so that it extends from the lacrimal sac through the ostium and extends into the nose.
Since the balloon DCR ostium is created by dilatation, rather than by excision or laser energy, there'is no threat to the surrounding ocular and orbital structures, and there is less tissue trauma.
As shown in U.S. Patent Nos. 5,021,043 and 5,169,043, 1 have previously co-invented balloon catheters for use in the lacrimal system. These balloon catheters are inserted from the eye through the small diameter (about 0.5mm) delicate punctum and canaliculus into the lacrimal sac extending through the planned ostium into the nose. The deflated profile diameter of the balloon catheter must be very small in order to be pushed through, and avoid damage to, the small diameter and delicate canaliculus. The need for such a small deflated diameter limits the inflated diameter of the balloon to 5mm. However, a 5mm diameter ostium is much smaller than the 17mm plus diameter ostium of an external DCR and leads to a higher stenosis rate of the balloon DCR ostium after surgery. A larger diameter balloon would create a larger-diameter ostium and lead to a higher surgical success rate.
This led to the concept disclosed beginning at column 7, line 29, and Fig. 4 of the 5,021,043 patent and beginning at column 8, line 34, and Fig. 4 of the 5,169,386 patent that a dilation catheter be introduced transnasally when a larger-diameter balloon is required. However, as taught in these patents, the dilation catheter is inserted over a guide wire. Although this technique is useful, it involves a number of time-consuming steps, including the insertion of a guide wire through the lacrimal system, and then separately advancing the balloon catheter over the guide wire. This technique requires the placement of a guide wire through the canaliculi into the nose. The surgeon then reaches up the nose with a hemostat or other instrument to grasp the guide wire and pull it out of the external naris of the nose. A flexible balloon catheter is then passed up the nose over the guide wire and through the lateral nasal wall into the lacrimal sac, or up the nasolacrimal duct into the lacrimal sac. However, there are problems with this method. First, there may be difficulty locating and grasping the guide wire in the nose, especially if even mild bleeding is present. The guide wire may pass posteriorly into the throat (pharynx) rather than in the direction of the external naris. There is often resistance to pulling the balloon from the nasal cavity into the lacrimal sac and considerable force is required to pull the balloon and guide wire into the lacrimal sac. This pull on the guide wire can cause it to slice through the delicate canaliculi, which may lead to secondary fibrosis and obstruction of the canaliculi after surgery.
The 5,169,386 patent also discloses an alternative dilation catheter, which does not use a guide wire, but there is no suggestion that this catheter be inserted transnasally. The catheter is constructed to simulate a standard ophthalmic probe in stiffness, in terms of both column strength and resistance to lateral bending, with sufficient flexibility to enable it to conform to the contours of the lacrimal system. The catheter, as provided, is initially straight, but the catheter may be bent between 0°- 30° to simulate the curvature of an ophthalmic probe. A curve retention element is inserted in the catheter to retain the curved shape and to increase the columnar and flexural stiffiiess of the distal portion of the catheter to enhance its ability to be forced through a constricted portion of the lacrimal system. The catheter is formed of a stainless steel hypotube having an outer diameter of 0.022" and an inner diameter of 0.017".
This catheter is not suitable for transnasal insertion. The tube does not have sufficient stiffness and column strength to enable the deflated balloon catheter to be pushed from the nasal cavity through a small, tight opening in the lateral nasal wall and lacrimal fossa into the lacrimal sac. Moreover, the bent distal portion is not angled to a degree necessary for ready insertion through the opening.
SUMMARY OF THE INVENTION A balloon catheter of the invention can be introduced transnasally into the area of a planned DCR ostium. The catheter has a larger deflated profile and, thus, a larger inflated diameter, than a balloon catheter introduced through the delicate canaliculi. The balloon catheter of the invention does not need a guide wire; and, therefore, there is no chance that a guide wire will damagβ'the delicate canaliculi. A larger diameter balloon DCR ostium is less likely to stenose after surgery and results in a better surgical success rate.
The balloon catheter of the invention comprises a hypotube formed of stainless steel of sufficient stiffiiess and column strength to enable the deflated balloon catheter to be pushed from the nasal cavity through a prepared small, tight opening in the lateral nasal wall and lacrimal fossa into the lacrimal sac. A distal end segment of the hypotube has a rounded bend, placing the distal segment at an angle of 70° to 115°, preferably 90°, to a long proximal segment or shaft. This bend allows the surgeon to rotate or shift the position of the long proximal catheter shaft, thus placing the distal balloon catheter segment in position to enter from the nasal cavity into the lacrimal sac at various angles appropriate to each individual patient. Due to the stiffiiess and strength of the hypotube, neither a guide wire nor a curve retention element are necessary.
The distal segment of the balloon catheter from the outside of the bend to the end of the catheter is 14mm which is short enough to allow it to be rotated within the nasal cavity and long enough to allow a balloon of sufficient length and diameter to be attached to the hypotube for dilatation of the balloon DCR ostium.
The balloon is formed of inflatable material with a first neck bonded with adhesive to the very distal portion of the distal segment of the hypotube and a second neck bonded with adhesive to the distal end of the proximal shaft, the bend, and the proximal end of the distal segment. This permits a longer working segment of balloon to be used, because the area of adhesion of the balloon includes the bend and the adjacent portion of the proximal long segment of the hypotube. The proximal end of the catheter tube has a luer lock with wings or an expansion to allow the catheter to be attached to tubing from the inflation device. The wings or expansion allow the surgeon to more easily hold, manipulate, and push the balloon catheter.
According to the method of the invention, a very large ostium is formed between the lacrimal sac and the nasal cavity with the use of a very large balloon inserted transnasally. The balloon is deflated to allow the catheter, which is of sufficient stiffness, to be pushed through the prepared opening formed from the nasal cavity through the lateral nasal wall and lacrimal fossa into the lacrimal sac. The balloon is then inflated to enlarge the opening and create the very large ostium. The balloon catheter is inserted without the use of a guide wire.
The portion of the distal end after the bend is sufficiently short to enable the catheter to be positioned in the nasal cavity to bring the distal end to the level of the prepared opening. The catheter is then rotated or shifted to align the distal end with the prepared opening, as required by the anatomy of the individual patient. The distal end is then pushed through the prepared opening to position the deflated balloon in the opening. The balloon is then inflated to enlarge the opening to the outer diameter of the inflated balloon, thus fora-ing the very large ostium.
Since the method of the insertion requires insertion of the balloon catheter transnasally, the trauma associated with insertion through the delicate canaliculi is avoided. The catheter and method of the invention provide a satisfactory endoscopic DCR and thus avoid the trauma associated with an external (incisional) DCR. The catheter and method of the invention achieve a high surgical success rate.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a schematic drawing of a preferred embodiment of a lacrimal balloon catheter of the invention;
Fig. la is a close-up schematic drawing of the tip of the distal segment of the balloon catheter of Fig. 1;
Fig. 2 is a schematic drawing of a step of the method of the invention showing a patient with an obstructed nasolacrimal duct in which a metal probe has been passed through the punctum, canaliculus, lacrimal sac, and multiple spots in the lacrimal fossa and lateral nasal wall into the nose;
Fig. 3 is a schematic drawing showing another step of the method of the invention in which a nerve hook brought up the nasal cavity, pushed into the small openings in the lateral nasal wall and lacrimal fossa, and moved to coalesce these small openings into a larger opening;
Fig. 4 is a schematic drawing showing a further step of the method of the invention in which a deflated balloon catheter of the invention, which has been brought into the nasal cavity and pushed through the small opening in the lateral nasal wall and lacrimal fossa into the lacrimal sac;'
Fig. 5 is a schematic drawing showing a step of the method of the invention in which the balloon catheter with the balloon inflated is within the ostium and lacrimal sac; and Fig. 6 is a close-up schematic drawing of the tip of the distal portion of an alternative embodiment of a balloon catheter of the invention; and
Fig. 7 is a schematic diagram showing a method step of an alternative embodiment of the method of the invention.
DETAILED DESCRIPTION
As shown in Figs. 1 and la, a balloon catheter 130 of the invention is assembled from a tube 136, preferably a stainless steel hard tempered hypotube which has a circular bend 138 of 0.13" radius such that distal segment 137 is oriented 70° to 115°, preferably 90°, to proximal segment 139. The distance from the distal tip 184 of distal segment 137 to the outer wall of proximal segment 139 of hypotube 136 is 4mm to 30mm, preferably 14mm, as shown in Fig. 1. The distal tip 184 of the hypotube 136 is closed, whereas the proximal end 142 is open. However, the lumen of tube 136 may be closed in the distal s ntie t 137, up to 10mm from the distal tip 184 allowing the distal tip 184 to remain open for engagement with a probe, as shown in Figs. 6 and 7. The proximal end 142 of hypotube 136 is inserted into a mold for forming luer 144. Heated plastic is injected into the mold to form luer 144 attached to proximal end 142. The inner diameter of the luer 144 matches the external diameter of the hypotube 136. The luer 144 has wings 143 or other enlargement or expansion on it to enable the surgeon to better hold and manipulate the balloon catheter 130. Catheter 130 is 4" to 10" long, preferable 6" in length as measured from proximal end 142 to distal tip 184, as shown in Fig. 1. The wall of tube 136 should be of such thickness that the tube has sufficient stiffiiess and column strength that distal segment 137 of a deflated catheter can be pushed through a prepared small, tight opening in the patient's lateral nasal wall. This may require considerable pressure in some cases. It has been found that a tube with a wall thickness of at least 0.035" will be satisfactory. A preferred tube has an outer diameter of 0.083" and an inner diameter of 0.039" with a wall thickness of 0.044". The catheter 130 has a port 140 in the distal segment 137, which is formed by inserting temporarily a discardable wire segment into the tube 136. This is done before inserting hypotube 136 into luer 144. A transverse slot is cut in the tube 136 approximately 2mm to 14mm, preferably 4mm, from its distal end 184 to form portT4θ) The slot extends in depth to approximately one third of the diameter of tube 136. A wire wheel is used to remove any burrs, and the discardable core wire is removed and discarded.
Catheter 130 has sufficient column strength and resistance to lateral bending (stiffiiess) to enable the deflated catheter to be pushed through the initial prepared opening in the lateral nasal wall and lacrimal fossa into the lacrimal sac. This may require considerable pressure in some cases.
A balloon 134 is preferably formed of polyethylene terephthalate and has a length of approximately 4mm to 30mm, preferably 14mm, and a working inflated diameter of 2mm to 14mm, preferably 9mm, for use in the lacrimal system. The balloon has a distal neck 170, a distal tapered region 172, a center region 174, a proximal tapered region 176, and a proximal neck 178. During installation, tube 136 is cleaned with isopropanol and then coated with a primer, "Loctite 770." The balloon is placed over the distal end of tube 136 to align the distal end of distal neck 170 with distal end 184 of tube 136. An adhesive, such as cyanoacrylate, is used. An acceptable adhesive "Loctite 4081" is available from Loctite Corporation. The adhesive is applied to distal end of distal neck 170 and the proximal end of proximal neck 178 to form bonds 180 and 182, respectively. The adhesive is applied to the balloon necks 170, 178 using a small mandrel such as a wire approximately 0.010" to 0.014" in diameter. The adhesive wicks into the necks due to capillary action. Proximal neck 178 and proximal tapered region 176 may be bonded oh distal segment 137 of tube 136 or extend over bend 138 onto the distal end portion of proximal segment 139 of tube 136. Extension of the proximal neck 178 onto bend 138 and proximal segment 139 allows a greater length of the working diameter, i.e., center region 174, to be on distal segment 137 of tube 136.
A first step of the method of the invention is shown in Fig. 2. A Bowman probe 102 is brought through superior punctum 4 of the patient's eye, superior canaliculus 6, common canaliculus 8, and lacrimal sac 10, and then pushed through the medial sac wall 11, lacrimal fossa bone 12, and lateral nasal wall 44 into the nasal cavity 38. Probe 102 is pulled back into lacrimal sac 10, and pushed through four or fives areas of medial sac wall 11, lacrimal fossa bone 12, and lateral nasal wall 44 into nasal cavity 38. The multiple openings 18 in the medial sac wall 11, lacrimal fossa 12, and lateral nasal wall 44 are coalesced into one prepared opening 19 (Fig. 4) by moving probe 102 in a see-saw fashion or by bringing a nerve hook 104 into nasal cavity 38, and pushing it into openings 18 and dragging nerve hook 104 across multiple openings, as shown in Fig. 3.
Turning to Fig. 4, the deflated transnasal lacrimal balloon catheter 130 is then brought into nasal cavity 38, and distal segment 137 is pushed through prepared opening 19 created by coalescing smaller openings 18 in lateral nasal wall 44, lacrimal fossa 12, and medial wall 11 of lacrimal sac 10, such that distal end 184 of distal segment 137 of balloon catheter 130 extends into lacrimal sac 10.
The luer lock 144 on proximal end 142 of balloon catheter 130 connects to the distal end 110 of tube 112 of the inflation device, which supplies fluid under pressure. As seen in Fig. 5, balloon 134 is inflated to 9 bars for 20 seconds to expand opening 19 to form ostium 120 then deflated. Distal segment 137 is then slightly repositioned to insure thorough dilation and inflated again to 9 bars for 20 seconds. Balloon 134 is then deflated and withdrawn from nasal cavity 38, leaving a large ostium 120 formed between lacrimal sac 10 and nasal cavity 38.
An alternative embodiment of the balloon catheter of the invention is shown in Fig. 6. In this embodiment, the catheter 230 has a distal segment 237, which are identical to catheter 130 and segment 137, as shown in Fig. 1, except for the point of closure of tube 136. Whereas, as described above, distal segment 137 in Fig. 1 is closed at its distal end 184, in the embodiment of Fig. 6, tube 236, and distal segment 237 are closed by closure wall 286 that is located between slot 140 Lnd the distal end 284. Since distal segment 237 is closed after (Sot 140 'fluid will still flow througlvslot 140)to irιflate(balloon 134Jwhen air under pressure is applied to tube 236. However, there will now be an open-ended tube segment 288 between closure wall 286 and distal end 284.
As shown in Fig. 7, this open-ended tube segment 288 may be used to receive an end of a probe 202, provided that the outer diameter of probe 202 is slightly smaller than the inner diameter of tube segment 288. Such a probe engaged with open-ended tube segment 288 can be useful for moving distal end 284 to a proper position for engagement with an opening 19 which is to be enlarged by inflating/balloon 13 1s described above.
It should be understood that the foregoing description of the invention is intended merely to be illustrative and other modifications, embodiments, and equivalents may be apparent to thpse skilled in the art without departing from the spirit and scope of the invention.
The invention claimed is:

Claims

A balloon catheter for dilating a prepared small, tight nasal opening in a wall separating a patient's lacrimal sac and the patient's nasal cavity, comprising: a tubular catheter body having a proximal end, a proximal segment, a distal end, and a distal segment;
an inflatable member disposed about said distal segment, said distal segment having a slot;
said catheter body being closed at a point that is closer to said distal end that is said slot;
means for applying fluid under pressure to said proximal end of said catheter body, said fluid under pressure flowing through said slot to inflate said inflatable member for dilating said prepared opening; and
said catheter body being formed of a hypotube of sufficient stiffiiess and column strength to enable said catheter, when said inflatable member is deflated, to be pushed from said nasal cavity through said prepared opening in said lateral nasal wall into said "lacrimal sac.
2. A balloon catheter of claim 1, wherein said catheter body is formed of stainless steel with a wall thickness of at least 0.035".
3. A balloon catheter of claim 2, wherein said catheter body has an outer diameter of 0.083 " and an inner diameter of 0.039" with a wall thickness of 0.044".
,
4. A balloon catheter of claim 1, wherein said distal segment has a rounded bend placing said distal segment at the angle of 70° to 115° to said proximal segment.
5. A balloon catheter of claim 4, wherein said distal segment is at an angle of 90° to said proximal segment.
6. A balloon catheter, of claim 1 , wherein said catheter body is closed at sai distal end.
7. A balloon catheter of claim 1, wherein said catheter body is closed at a point spaced from said distal end and between said slot and said distal end, whereby an open-ended distal portion of said distal segment is provided, said open-ended distal portion being engagable by an end of a probe to help guide said catheter body.
8. A balloon catheter for dilating a prepared opening in a lateral nasal wall separating a patient's lacrimal sac and the patient's nasal cavity, comprising:
a tubular catheter body having a proximal end, a proximal segment, a distal end, and a distal segment;
an inflatable member disposed about said distal segment, said distal segment having a slot;
said catheter body being closed at a point that is closer to said distal end that is said slot;
means for applying fluid under pressure to said proximal end of said catheter body, said fluid under pressure flowing through said slot to inflate said inflatable member for dilating said prepared opening; and
said distal segment having a rounded bend placing said distal segment at an angle of 70° to 115° to said proximal segment.
9. A balloon catheter of claim 8, wherein said distal segment is at an angle of 90° to said proximal segment.
10. A balloon catheter of claim 8, wherein said inflatable member comprises a distal neck, a center region, and a proximal neck and said proximal neck is adhesively bonded to the proximal end of said distal segment and said bend, said distal neck is adhesively bonded to the portion of said distal segment between said slot and said distal end, thereby allowing a greater length of said center region to be on said distal segment.
11. A balloon catheter of claim 8, wherein said inflatable member comprises a distal neck, a center region, and a proximal neck and said proximal neck is adhesively bonded to the proximal end of said distal segment, the distal end of said proximal segment, and said bend, said distal neck is adhesively bonded to the portion of said distal segment between said slot and said distal end, thereby allowing a greater length of said center region to be on said distal segment.
12. A method forming a relatively large opening in a lateral nasal wall separating a patient's lacrimal sac and nasal cavity, comprising:
providing a balloon catheter having a tubular catheter body formed with a proximal segment, a bend, and a distal segment at an angle of 70° to 115° with said proximal segment, an inflatable member mounted around said distal segment, a slot through a wall of said distal segment within said inflatable member, said tubular catheter body being closed at a point distally of said slot, and means for providing fluid under pressure at the proximal end of said tubular catheter body to inflate said inflatable member;
forming a small, tight prepared opening through the patient's medial sac wall and lacrimal fossa, and said lateral nasal wall with one or more surgical tools, said opening being of such size that it will snugly receive said distal segment with said inflatable member deflated;
pushing said distal segment of said catheter body into said prepared opening with said inflatable member deflated; and
introducing said fluid under pressure through said proximal end of said catheter body and said slot to inflate said inflatable body and dilate said prepared opening.
13. The method of claim 12, further comprising deflating said inflatable body, slightly repositioning said distal segment and re-inflating said inflatable member to insure thorough dilation of said prepared opening.
14. The method of claim 12, wherein said inflatable member is inflated to nine bars for twenty seconds.
15. The method of claim 12, wherein said step of forming said prepared opening comprises bringing a Bowman probe through the patient's superior punctum, superior canaliculus, common canaliculus, and lacrimal sac and pushing said probe through the patient's medial sac wall, lacrimal fossa bone, and lateral nasal wall into the patient's nasal cavity to form a small opening.
16. The method of claim 15, further comprising repeating said pushing of said probe to form several small openings through said medial sac wall, lacrimal fossa bone, and lateral nasal wall into said nasal cavity.
17. The method of claim 16, further comprising coalescing said several small openings to form said prepared openings by moving said probe in a see-saw fashion within said several openings.
18. The method of claim 16, further comprising coalescing said several small openings to form said prepared opening by bringing a nerve hook across said several small openings.
• 19. The method of claim 12, wherein said catheter body is formed of a hypotube of sufficient stiffiiess and column strength to enable said distal segment with said inflatable member deflated to be pushed through said prepared opening.
20. The method of claim 12, wherein said proximal segment is introduced into a patient's nasal cavity until said distal segment is moved to a point adjacent said prepared opening, and said proximal segment is rotated to align said distal segment with said prepared opening to facilitate entry of said distal segment into said prepared opening.
21. The method of claim 12, wherein said tubular catheter body is closed at a point short of the distal end of said catheter body to provide an open-ended portion of said distal segment, and wherein said method further comprises inserting a probe into said open- ended portion to facilitate movement of said distal segment to a desired location.
22. A method forming a relatively large opening in a lateral nasal wall separating a patient's lacrimal sac and nasal cavity, comprising:
providing a balloon catheter having a tubular catheter body formed with a proximal segment and a distal segment, an inflatable member mounted around said distal segment, a slot through a wall of said distal segment within said inflatable member, said tubular catheter body being closed at a point distally of said slot, and means for providing fluid under pressure at the proximal end of said tubular catheter body to inflate said inflatable member, said catheter body being formed of a hypotube of sufficient stiffness and column strength to enable said catheter, when said inflatable member is deflated, to be pushed from said nasal cavity through a small, tight prepared opening into said lacrimal sac;
forming a prepared opening through said lateral nasal wall with one or more surgical tools, said opening being of such size that it will snugly receive said distal segment with said inflatable member deflated;
pushing said distal segment of said catheter body into said prepared opening with said inflatable member deflated; and
introducing said fluid under pressure through said proximal end of said catheter body and said slot to inflate said inflatable body and dilate said prepared opening.
23. The method of claim 22, further comprising deflating said inflatable body, slightly repositioning said distal segment and re-inflating said inflatable member to insure thorough dilation of said prepared opening.
PCT/US2003/030691 2002-09-30 2003-09-30 Transnasal method and catheter for lacrimal system Ceased WO2004030720A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
CA2499222A CA2499222C (en) 2002-09-30 2003-09-30 Transnasal method and catheter for lacrimal system
JP2004541840A JP2006515997A (en) 2002-09-30 2003-09-30 Nasal method and catheter for lacrimal system
MXPA05003261A MXPA05003261A (en) 2002-09-30 2003-09-30 Transnasal method and catheter for lacrimal system.
AU2003273371A AU2003273371A1 (en) 2002-09-30 2003-09-30 Transnasal method and catheter for lacrimal system
EP03755869A EP1545647B1 (en) 2002-09-30 2003-09-30 Transnasal catheter for lacrimal system

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/259,630 2002-09-30
US10/259,630 US7169163B2 (en) 2002-09-30 2002-09-30 Transnasal method and catheter for lacrimal system

Publications (2)

Publication Number Publication Date
WO2004030720A2 true WO2004030720A2 (en) 2004-04-15
WO2004030720A3 WO2004030720A3 (en) 2005-01-27

Family

ID=32029528

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/030691 Ceased WO2004030720A2 (en) 2002-09-30 2003-09-30 Transnasal method and catheter for lacrimal system

Country Status (8)

Country Link
US (3) US7169163B2 (en)
EP (1) EP1545647B1 (en)
JP (1) JP2006515997A (en)
CN (1) CN1307958C (en)
AU (1) AU2003273371A1 (en)
CA (1) CA2499222C (en)
MX (1) MXPA05003261A (en)
WO (1) WO2004030720A2 (en)

Families Citing this family (136)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10105592A1 (en) 2001-02-06 2002-08-08 Achim Goepferich Placeholder for drug release in the frontal sinus
US8317816B2 (en) 2002-09-30 2012-11-27 Acclarent, Inc. Balloon catheters and methods for treating paranasal sinuses
CA2518960C (en) 2003-03-14 2013-08-27 Sinexus, Inc. Sinus delivery of sustained release therapeutics
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
US10188413B1 (en) 2004-04-21 2019-01-29 Acclarent, Inc. Deflectable guide catheters and related methods
US7419497B2 (en) 2004-04-21 2008-09-02 Acclarent, Inc. Methods for treating ethmoid disease
US9399121B2 (en) 2004-04-21 2016-07-26 Acclarent, Inc. Systems and methods for transnasal dilation of passageways in the ear, nose or throat
US9554691B2 (en) 2004-04-21 2017-01-31 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US8146400B2 (en) 2004-04-21 2012-04-03 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US9089258B2 (en) 2004-04-21 2015-07-28 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US8894614B2 (en) 2004-04-21 2014-11-25 Acclarent, Inc. Devices, systems and methods useable for treating frontal sinusitis
US7361168B2 (en) 2004-04-21 2008-04-22 Acclarent, Inc. Implantable device and methods for delivering drugs and other substances to treat sinusitis and other disorders
US9351750B2 (en) 2004-04-21 2016-05-31 Acclarent, Inc. Devices and methods for treating maxillary sinus disease
US8932276B1 (en) 2004-04-21 2015-01-13 Acclarent, Inc. Shapeable guide catheters and related methods
US7720521B2 (en) 2004-04-21 2010-05-18 Acclarent, Inc. Methods and devices for performing procedures within the ear, nose, throat and paranasal sinuses
US8747389B2 (en) 2004-04-21 2014-06-10 Acclarent, Inc. Systems for treating disorders of the ear, nose and throat
US7559925B2 (en) 2006-09-15 2009-07-14 Acclarent Inc. Methods and devices for facilitating visualization in a surgical environment
US7803150B2 (en) * 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
US20190314620A1 (en) 2004-04-21 2019-10-17 Acclarent, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US20060063973A1 (en) * 2004-04-21 2006-03-23 Acclarent, Inc. Methods and apparatus for treating disorders of the ear, nose and throat
US7462175B2 (en) 2004-04-21 2008-12-09 Acclarent, Inc. Devices, systems and methods for treating disorders of the ear, nose and throat
US20070208252A1 (en) * 2004-04-21 2007-09-06 Acclarent, Inc. Systems and methods for performing image guided procedures within the ear, nose, throat and paranasal sinuses
US20060004323A1 (en) * 2004-04-21 2006-01-05 Exploramed Nc1, Inc. Apparatus and methods for dilating and modifying ostia of paranasal sinuses and other intranasal or paranasal structures
US7654997B2 (en) * 2004-04-21 2010-02-02 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitus and other disorders of the ears, nose and/or throat
US20070167682A1 (en) 2004-04-21 2007-07-19 Acclarent, Inc. Endoscopic methods and devices for transnasal procedures
US9101384B2 (en) 2004-04-21 2015-08-11 Acclarent, Inc. Devices, systems and methods for diagnosing and treating sinusitis and other disorders of the ears, Nose and/or throat
US8702626B1 (en) 2004-04-21 2014-04-22 Acclarent, Inc. Guidewires for performing image guided procedures
US7410480B2 (en) * 2004-04-21 2008-08-12 Acclarent, Inc. Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
US8764729B2 (en) 2004-04-21 2014-07-01 Acclarent, Inc. Frontal sinus spacer
US8864787B2 (en) 2004-04-21 2014-10-21 Acclarent, Inc. Ethmoidotomy system and implantable spacer devices having therapeutic substance delivery capability for treatment of paranasal sinusitis
EP1765454B1 (en) 2004-07-02 2016-04-13 Mati Therapeutics Inc. Treatment medium delivery device for the eye
KR100675379B1 (en) * 2005-01-25 2007-01-29 삼성전자주식회사 Printing system and printing method
EP2298318A1 (en) 2005-04-04 2011-03-23 Sinexus, Inc. Device and methods for treating paranasal sinus conditions
US20060276738A1 (en) * 2005-06-06 2006-12-07 Becker Bruce B Lacrimal drainage bypass device and method
US8951225B2 (en) * 2005-06-10 2015-02-10 Acclarent, Inc. Catheters with non-removable guide members useable for treatment of sinusitis
WO2007028005A2 (en) * 2005-09-01 2007-03-08 Bristol-Myers Squibb Company Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
US8114113B2 (en) 2005-09-23 2012-02-14 Acclarent, Inc. Multi-conduit balloon catheter
US20070179518A1 (en) * 2006-02-02 2007-08-02 Becker Bruce B Balloon Catheters and Methods for Treating Paranasal Sinuses
EP2004172B1 (en) 2006-03-31 2019-03-13 Mati Therapeutics Inc. Drug delivery structures and compositions for nasolacrimal system
US7520876B2 (en) 2006-04-21 2009-04-21 Entellus Medical, Inc. Device and method for treatment of sinusitis
US8657846B2 (en) 2006-04-21 2014-02-25 Entellus Medical, Inc. Guide catheter and method of use
CA2651935C (en) * 2006-05-12 2016-03-15 Entrigue Surgical, Inc. Middle turbinate medializer
US8190389B2 (en) 2006-05-17 2012-05-29 Acclarent, Inc. Adapter for attaching electromagnetic image guidance components to a medical device
US20080294255A1 (en) * 2006-05-23 2008-11-27 Donald Albert Gonzales Sinus Tube
US8038712B2 (en) * 2006-06-29 2011-10-18 Koninklijke Philips Electronics N.V. Methods and devices for rhinoplasty and treating internal valve stenosis
US8535707B2 (en) * 2006-07-10 2013-09-17 Intersect Ent, Inc. Devices and methods for delivering active agents to the osteomeatal complex
US7547323B2 (en) * 2006-08-29 2009-06-16 Sinexus, Inc. Stent for irrigation and delivery of medication
US9820688B2 (en) * 2006-09-15 2017-11-21 Acclarent, Inc. Sinus illumination lightwire device
US8439687B1 (en) 2006-12-29 2013-05-14 Acclarent, Inc. Apparatus and method for simulated insertion and positioning of guidewares and other interventional devices
US20080172033A1 (en) * 2007-01-16 2008-07-17 Entellus Medical, Inc. Apparatus and method for treatment of sinusitis
US8118757B2 (en) 2007-04-30 2012-02-21 Acclarent, Inc. Methods and devices for ostium measurement
US8485199B2 (en) 2007-05-08 2013-07-16 Acclarent, Inc. Methods and devices for protecting nasal turbinate during surgery
US20090030409A1 (en) * 2007-07-27 2009-01-29 Eric Goldfarb Methods and devices for facilitating visualization in a surgical environment
ES2732555T3 (en) 2007-09-07 2019-11-25 Mati Therapeutics Inc Tear implants and related methods
EP2207529B1 (en) * 2007-09-07 2014-12-31 Mati Therapeutics Inc. Drug cores for sustained release of therapeutic agents
US9011361B2 (en) 2007-09-07 2015-04-21 Mati Therapeutics Inc. Lacrimal implant detection
MX2010002618A (en) * 2007-09-07 2010-11-10 Qlt Plug Delivery Inc Insertion and extraction tools for lacrimal implants.
AU2008298703B2 (en) * 2007-09-14 2014-06-26 Arthrocare Corporation Implant system
US9375327B2 (en) 2007-12-12 2016-06-28 Intact Vascular, Inc. Endovascular implant
US10166127B2 (en) 2007-12-12 2019-01-01 Intact Vascular, Inc. Endoluminal device and method
US9603730B2 (en) 2007-12-12 2017-03-28 Intact Vascular, Inc. Endoluminal device and method
US7896911B2 (en) 2007-12-12 2011-03-01 Innovasc Llc Device and method for tacking plaque to blood vessel wall
US8128677B2 (en) 2007-12-12 2012-03-06 Intact Vascular LLC Device and method for tacking plaque to a blood vessel wall
US10022250B2 (en) 2007-12-12 2018-07-17 Intact Vascular, Inc. Deployment device for placement of multiple intraluminal surgical staples
US20090198179A1 (en) * 2007-12-18 2009-08-06 Abbate Anthony J Delivery devices and methods
US10206821B2 (en) 2007-12-20 2019-02-19 Acclarent, Inc. Eustachian tube dilation balloon with ventilation path
CA2715489C (en) * 2008-02-18 2017-09-19 Qlt Plug Delivery, Inc. Lacrimal implants and their use in the treatment of eye disorders
US8182432B2 (en) 2008-03-10 2012-05-22 Acclarent, Inc. Corewire design and construction for medical devices
WO2009134371A2 (en) 2008-04-30 2009-11-05 Qlt Plug Delivery, Inc. Composite lacrimal insert and related methods
MX2010012022A (en) * 2008-05-09 2011-03-15 Qlt Plug Delivery Inc Sustained release delivery of active agents to treat glaucoma and ocular hypertension.
USD631541S1 (en) * 2008-06-18 2011-01-25 International Medical, Inc. Dacryocyst drainage tube
ES2700863T3 (en) 2008-07-30 2019-02-19 Acclarent Inc Devices for localization of the paranasal ostium
AU2009276505B2 (en) 2008-08-01 2015-04-23 Intersect Ent, Inc. Methods and devices for crimping self-expanding devices
CA2736756C (en) 2008-09-17 2017-10-31 Entrigue Surgical, Inc. Methods and systems for medializing a turbinate
EP2323724A1 (en) 2008-09-18 2011-05-25 Acclarent, Inc. Methods and apparatus for treating disorders of the ear nose and throat
WO2010096822A2 (en) * 2009-02-23 2010-08-26 Qlt Plug Delivery, Inc. Lacrimal implants and related methods
US20100241155A1 (en) 2009-03-20 2010-09-23 Acclarent, Inc. Guide system with suction
US7978742B1 (en) 2010-03-24 2011-07-12 Corning Incorporated Methods for operating diode lasers
US8435290B2 (en) 2009-03-31 2013-05-07 Acclarent, Inc. System and method for treatment of non-ventilating middle ear by providing a gas pathway through the nasopharynx
CA2761769C (en) * 2009-05-15 2018-06-05 Intersect Ent, Inc. Expandable devices and methods therefor
US8834513B2 (en) 2009-06-05 2014-09-16 Entellus Medical, Inc. Method and articles for treating the sinus system
US8282667B2 (en) * 2009-06-05 2012-10-09 Entellus Medical, Inc. Sinus dilation catheter
US20100312338A1 (en) * 2009-06-05 2010-12-09 Entrigue Surgical, Inc. Systems, devices and methods for providing therapy to an anatomical structure
WO2011008981A1 (en) * 2009-07-15 2011-01-20 Regents Of The University Of Minnesota Implantable devices for treatment of sinusitis
US8435261B2 (en) 2009-07-15 2013-05-07 Regents Of The University Of Minnesota Treatment and placement device for sinusitis applications
US8888686B2 (en) 2009-09-23 2014-11-18 Entellus Medical, Inc. Endoscope system for treatment of sinusitis
WO2011130639A1 (en) 2010-04-15 2011-10-20 Entellus Medical, Inc. Method and apparatus for treating dilating the ethmoid infundibulum
WO2011140535A1 (en) 2010-05-07 2011-11-10 Entellus Medical, Inc. Sinus balloon dilation catheters and sinus surgury tools
US9155492B2 (en) 2010-09-24 2015-10-13 Acclarent, Inc. Sinus illumination lightwire device
US9022967B2 (en) 2010-10-08 2015-05-05 Sinopsys Surgical, Inc. Implant device, tool, and methods relating to treatment of paranasal sinuses
EP2640319B1 (en) 2010-11-16 2016-10-19 TriVascular, Inc. Advanced endovascular graft and delivery system
CA2817589A1 (en) 2010-11-16 2012-05-24 The Board Of Trustees Of The Leland Stanford Junior University Systems and methods for treatment of dry eye
US9821159B2 (en) 2010-11-16 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Stimulation devices and methods
US10285831B2 (en) 2011-06-03 2019-05-14 Intact Vascular, Inc. Endovascular implant
US9486614B2 (en) 2011-06-29 2016-11-08 Entellus Medical, Inc. Sinus dilation catheter
ES2727203T3 (en) 2011-08-29 2019-10-14 Mati Therapeutics Inc Administration for sustained release of active agents to treat glaucoma and ocular hypertension
US9974685B2 (en) 2011-08-29 2018-05-22 Mati Therapeutics Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
US9283360B2 (en) 2011-11-10 2016-03-15 Entellus Medical, Inc. Methods and devices for treating sinusitis
CN107157632B (en) 2012-01-25 2021-05-25 因特脉管有限公司 Endoluminal device and method
EP2836170B1 (en) 2012-04-11 2018-02-14 Sinopsys Surgical, Inc. Implantation tools, tool assemblies and kits
US9066828B2 (en) * 2012-06-15 2015-06-30 Trivascular, Inc. Endovascular delivery system with flexible and torqueable hypotube
CA2892322C (en) 2013-01-25 2017-05-30 Sinopsys Surgical, Inc. Paranasal sinus access implant devices and related tools and kits
WO2014138709A1 (en) 2013-03-08 2014-09-12 Oculeve, Inc. Devices and methods for treating dry eye in animals
US9717627B2 (en) 2013-03-12 2017-08-01 Oculeve, Inc. Implant delivery devices, systems, and methods
JP6399663B2 (en) 2013-03-14 2018-10-03 インターセクト エント， インコーポレイテッド System, device and method for treating sinus conditions
US9629684B2 (en) 2013-03-15 2017-04-25 Acclarent, Inc. Apparatus and method for treatment of ethmoid sinusitis
US9433437B2 (en) 2013-03-15 2016-09-06 Acclarent, Inc. Apparatus and method for treatment of ethmoid sinusitis
EP2986339A4 (en) 2013-04-19 2016-12-21 Oculeve Inc DEVICES AND METHODS FOR NASAL STIMULATION
CN105828755B (en) 2013-10-16 2019-01-22 西诺普西斯外科股份有限公司 Devices, tools, kits and methods related to fluid manipulation treatment of the sinuses
JP6604963B2 (en) 2014-02-25 2019-11-20 オキュリーブ， インコーポレイテッド Polymer formulations for nasolacrimal gland stimulation
WO2016015002A1 (en) 2014-07-24 2016-01-28 Sinopsys Surgical, Inc. Paranasal sinus access implant devices and related products and methods
CA2956176A1 (en) 2014-07-25 2016-01-28 Oculeve, Inc. Stimulation patterns for treating dry eye
US10207108B2 (en) 2014-10-22 2019-02-19 Oculeve, Inc. Implantable nasal stimulator systems and methods
JP6735742B2 (en) 2014-10-22 2020-08-05 オキュリーブ， インコーポレイテッド Stimulator and method for the treatment of dry eye
AU2015335772B2 (en) 2014-10-22 2020-07-09 Oculeve, Inc. Contact lens for increasing tear production
US10322269B1 (en) 2015-01-19 2019-06-18 Dalent, LLC Dilator device
JP2018504209A (en) 2015-01-22 2018-02-15 インターセクト エント， インコーポレイテッド Drug coated balloon
US9375336B1 (en) 2015-01-29 2016-06-28 Intact Vascular, Inc. Delivery device and method of delivery
US9433520B2 (en) 2015-01-29 2016-09-06 Intact Vascular, Inc. Delivery device and method of delivery
CN112426253B (en) 2015-05-27 2025-04-11 特里瓦斯库拉尔公司 Balloon-assisted endoluminal prosthesis deployment
EP3328326A4 (en) 2015-07-30 2019-03-20 TriVascular, Inc. DEVICES AND METHODS FOR DEPLOYING ENDOLUMINAL PROSTHESIS
US10426958B2 (en) 2015-12-04 2019-10-01 Oculeve, Inc. Intranasal stimulation for enhanced release of ocular mucins and other tear proteins
US10993824B2 (en) 2016-01-01 2021-05-04 Intact Vascular, Inc. Delivery device and method of delivery
US10252048B2 (en) 2016-02-19 2019-04-09 Oculeve, Inc. Nasal stimulation for rhinitis, nasal congestion, and ocular allergies
US10918864B2 (en) 2016-05-02 2021-02-16 Oculeve, Inc. Intranasal stimulation for treatment of meibomian gland disease and blepharitis
RU2019118600A (en) 2016-12-02 2021-01-11 Окулив, Инк. APPARATUS AND METHOD FOR MAKING DRY EYE SYNDROME PREDICTION AND TREATMENT RECOMMENDATIONS
US11660218B2 (en) 2017-07-26 2023-05-30 Intact Vascular, Inc. Delivery device and method of delivery
AU2018338092B2 (en) 2017-09-20 2024-06-13 Sinopsys Surgical, Inc. Paranasal sinus fluid access implantation tools, assemblies, kits and methods
US11141176B2 (en) * 2017-09-27 2021-10-12 Tearflow Care Ltd. Tools and methods for dacryocystorhinostomy
CN112533550A (en) * 2018-07-24 2021-03-19 半影公司 Device and method for controlled clot aspiration
CN110051468A (en) * 2019-03-08 2019-07-26 苏州莱诺医疗器械有限公司 A kind of nasolacrimal duct sacculus dilating catheter
USD877325S1 (en) 2019-06-06 2020-03-03 Dalent, LLC Inflatable therapeutic treatment balloon device
EP3982851A4 (en) 2019-06-11 2023-08-16 Dalent, LLC BALLOON DILATING DEVICE
US12403291B2 (en) 2019-08-30 2025-09-02 Intersect Ent, Inc. Submucosal bioresorbable drug eluting platform
CN113018650A (en) * 2021-02-26 2021-06-25 中国人民解放军总医院第三医学中心 Lacrimal passage drainage tube capable of expanding and carrying medicine
CN114602039A (en) * 2022-04-02 2022-06-10 温州医科大学附属眼视光医院 Lacrimal sac dilatation balloon for improving success rate of dacryocyst and nasal cavity anastomosis operation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021043A (en) 1989-09-11 1991-06-04 C. R. Bard, Inc. Method and catheter for dilatation of the lacrimal system
US5169386A (en) 1989-09-11 1992-12-08 Bruce B. Becker Method and catheter for dilatation of the lacrimal system

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3889685A (en) * 1973-11-02 1975-06-17 Cutter Lab Tubular unit with vessel engaging cuff structure
US4323071A (en) * 1978-04-24 1982-04-06 Advanced Catheter Systems, Inc. Vascular guiding catheter assembly and vascular dilating catheter assembly and a combination thereof and methods of making the same
US4380237A (en) * 1979-12-03 1983-04-19 Massachusetts General Hospital Apparatus for making cardiac output conductivity measurements
US4437856A (en) * 1981-02-09 1984-03-20 Alberto Valli Peritoneal catheter device for dialysis
FR2502499B1 (en) * 1981-03-27 1987-01-23 Farcot Jean Christian APPARATUS FOR BLOOD RETROPERFUSION, IN PARTICULAR FOR THE TREATMENT OF INFARCTUS BY INJECTION OF ARTERIAL BLOOD INTO THE CORONARY SINUS
US4777951A (en) * 1986-09-19 1988-10-18 Mansfield Scientific, Inc. Procedure and catheter instrument for treating patients for aortic stenosis
US4771776A (en) * 1987-01-06 1988-09-20 Advanced Cardiovascular Systems, Inc. Dilatation catheter with angled balloon and method
US5021045A (en) * 1988-04-28 1991-06-04 Research Medical, Inc. Retrograde venous cardioplegia catheters and methods of use and manufacture
US4946440A (en) * 1988-10-05 1990-08-07 Hall John E Evertible membrane catheter and method of use
US4943275A (en) * 1988-10-14 1990-07-24 Abiomed Limited Partnership Insertable balloon with curved support
CN1048500A (en) * 1990-05-13 1991-01-16 焦云河 Ductus nasolacrimalis recanalization surgical instrument
CN2077268U (en) * 1990-05-19 1991-05-22 谭恒昶 Combined instrument for lacrimal passage obstruction silica gel strip embedding operation
US5228441A (en) * 1991-02-15 1993-07-20 Lundquist Ingemar H Torquable catheter and method
US5338295A (en) * 1991-10-15 1994-08-16 Scimed Life Systems, Inc. Dilatation catheter with polyimide-encased stainless steel braid proximal shaft
US5390339A (en) * 1991-10-23 1995-02-14 Motorola Inc. Method and apparatus for selecting a serving transceiver
JP2979804B2 (en) * 1991-12-13 1999-11-15 株式会社ニッショー Aortic occlusion balloon catheter
US6113567A (en) * 1995-10-25 2000-09-05 Becker; Bruce B. Lacrimal silicone tube with reduced friction
CN2250160Y (en) * 1995-12-05 1997-03-26 张敬先 Lacrimal duct retrograde implanting tube operation equipment
FR2743498B1 (en) * 1996-01-12 1998-03-06 Sadis Bruker Spectrospin PROBE, IN PARTICULAR URETHRAL PROBE, FOR THE HEATING OF TISSUES BY MICROWAVES AND FOR THE MEASUREMENT OF TEMPERATURE BY RADIOMETRY
US5928192A (en) * 1997-07-24 1999-07-27 Embol-X, Inc. Arterial aspiration
US6083188A (en) * 1998-02-04 2000-07-04 Becker; Bruce B. Lacrimal silicone stent with very large diameter segment insertable transnasally
US6248121B1 (en) * 1998-02-18 2001-06-19 Cardio Medical Solutions, Inc. Blood vessel occlusion device
KR20020035476A (en) * 1999-04-26 2002-05-11 지엠피 비젼 솔루션즈 인코포레이티드 Shunt device and method for treating glaucoma
US6520977B2 (en) * 1999-12-06 2003-02-18 Hadi Piraka Uterine balloon apparatus and method
EP2335660B1 (en) * 2001-01-18 2018-03-28 The Regents of The University of California Minimally invasive glaucoma surgical instrument
US6757545B2 (en) * 2001-03-01 2004-06-29 Steven P. Nowak Location information management system and method for mobile communications unit
US20030054837A1 (en) * 2001-09-17 2003-03-20 Ennis Mark Kieran Telephone call routing system and method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5021043A (en) 1989-09-11 1991-06-04 C. R. Bard, Inc. Method and catheter for dilatation of the lacrimal system
US5169386A (en) 1989-09-11 1992-12-08 Bruce B. Becker Method and catheter for dilatation of the lacrimal system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1545647A4

Also Published As

Publication number Publication date
JP2006515997A (en) 2006-06-15
CA2499222A1 (en) 2004-04-15
US20070123924A1 (en) 2007-05-31
CN1684647A (en) 2005-10-19
AU2003273371A1 (en) 2004-04-23
EP1545647A4 (en) 2008-04-30
US7169163B2 (en) 2007-01-30
WO2004030720A3 (en) 2005-01-27
CN1307958C (en) 2007-04-04
EP1545647A2 (en) 2005-06-29
US20040064083A1 (en) 2004-04-01
MXPA05003261A (en) 2005-10-18
US20130131713A1 (en) 2013-05-23
CA2499222C (en) 2012-08-28
EP1545647B1 (en) 2012-05-23

Similar Documents

Publication Publication Date Title
US7169163B2 (en) Transnasal method and catheter for lacrimal system
US8317816B2 (en) Balloon catheters and methods for treating paranasal sinuses
US9700706B2 (en) Nasolacrimal obstruction treatment device and method
US8979789B2 (en) In vivo punctal anchoring method for lacrimal stents
US8562554B2 (en) Side-by-side lacrimal intubation threader device
US6083188A (en) Lacrimal silicone stent with very large diameter segment insertable transnasally
US20090204142A1 (en) Nasolacrimal system surgical tool and method
US20070179518A1 (en) Balloon Catheters and Methods for Treating Paranasal Sinuses
US10207091B2 (en) Force-directional nasal surgery dilatation device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003755869

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2499222

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 20038227754

Country of ref document: CN

Ref document number: 2004541840

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: PA/a/2005/003261

Country of ref document: MX

WWP Wipo information: published in national office

Ref document number: 2003755869

Country of ref document: EP